Drug Database
Back to search

Poland· PL-100060364

Acebutolol Gedeon Richter

A acebutolol product containing acebutololum, registered in Poland by Gedeon Richter Polska Sp. z o.o.. The same ATC class is registered in 10 of our 19 countries.

ATC C07AB04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAcebutolol Gedeon RichterATCC07AB04REGISTER NO.PL-100060364PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acebutololumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acebutolol is registered in 10 of 19 countries.

Countries holding a registration under ATC C07AB04 (acebutolol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search acebutolol products by name

Acebutolol · ATC C07AB04

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acebutolol costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Acebutolol · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

  • FR France$0.28
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Acebutololum
Manufacturer
Gedeon Richter Polska Sp. z o.o.
Country
Poland (PL)
ATC code
C07AB04
ATC class
Acebutolol
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

1 priced
  • gtin
    05909990109920
    30 szt.
    PLN 11.36
  • gtin
    05909990109913

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

295 interactions on record for acebutolol.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acebutolol against other medicinesHow interaction checks work

Acebutolol · interactions on record

295 records

  • 11 severe
  • 184 moderate
  • 21 minor
  • 79 info

Most severe, free to view

  • DolasetronA04AA04severe
  • TheophyllinC01EB28severe
  • CeritinibL01ED02severe
  • CeritinibL01XE28severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Acebutolol in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All acebutolol products

Authorised across Europe · EMA

The same active substance is authorised in 5 EEA countries. Names it is sold under:

  • Czechia · Acecor, Sectral
  • France · Acebutolol Almus, Acebutolol Arrow Lab
  • United Kingdom (Northern Ireland) · Acebutolol Milpharm, Sectral
  • Italy · Sectral
  • Netherlands · Acebutolol Hydrochloride Aurobindo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c2d7a809-d126-4235-a216-5c1c25ae455b
GET /v1/drugs/c2d7a809-d126-4235-a216-5c1c25ae455b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "200 mg",
  "packaging": "05909990109913 ¦ Rp ¦ Skasowane ¦ 9006\n20 tabl.\n05909990109920 ¦ Rp ¦ 13191\n30 tabl.",
  "substance": "Acebutololi hydrochloridum 221.7 mg",
  "common_name": "Acebutololum",
  "pl_product_id": "100060364",
  "pozwolenie_nr": "01099",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about acebutolol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console